News Information

News Information

Company News

Industry News

Conferences

Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly

Release time:

2026-02-03

Picture Name

Zonsen PepLib Biotech and Novartis Sign Worldwide License Agreement regarding Radioligand Therapy Asset

2026-01-13

Picture Name

Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly

2026-02-03

Picture Name

PepLib Closes Series B to Accelerate Commercialization of Peptide Pipelines

2025-12-31

PepLib aims to promote the development and accessibility of innovative peptide drugs, benefiting global patients and human health while keeping costs low.

Contact

Email：info@peplib.com

Address：21 Bridge St, Metuchen, NJ 08840

Follow

图片名称
Submit Message

Copyright©2023 Zonsen PepLib Biotech Inc. This website supports IPV6

SEO Tags| Website Construction: Power of Chinese EnterprisesChangsha 

Business License
LOGO
Search